NTI — Neurotech International Balance Sheet
0.000.00%
- AU$17.84m
- AU$14.81m
- AU$2.58m
Annual balance sheet for Neurotech International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.83 | 1.9 | 5.03 | 11.6 | 3.03 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.143 | 0.099 | 0.258 | 0.318 | 0.089 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 5.01 | 2.02 | 5.31 | 12.2 | 3.24 |
| Net Property, Plant And Equipment | 0 | 0.003 | 0.001 | 0 | 0 |
| Total Assets | 5.01 | 2.02 | 5.31 | 12.2 | 3.24 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 0.349 | 0.593 | 1.35 | 0.315 | 0.286 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.14 | 0.593 | 1.35 | 0.315 | 0.286 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3.86 | 1.43 | 3.96 | 11.9 | 2.95 |
| Total Liabilities & Shareholders' Equity | 5.01 | 2.02 | 5.31 | 12.2 | 3.24 |
| Total Common Shares Outstanding |